www.fdanews.com/articles/156662-fda-grants-breakthrough-status-to-novartis-investigational-drug
FDA Grants Breakthrough Status to Novartis Investigational Drug
June 26, 2013
The FDA has awarded Novartis breakthrough therapy designation for its heart failure drug, the second such breakthrough designation the company has received this year.
PharmTech
PharmTech